Journal of Ovarian Research

Papers
(The H4-Index of Journal of Ovarian Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis177
The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome160
Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report78
Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance73
Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study61
HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer61
Integrated multi-omics analysis identifies TLR4-mediated mechanisms in ATBC-induced ovarian dysfunction and female infertility: A network toxicology, transcriptomic, and Mendelian randomization study58
Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis57
Effects of vitrified cryopreservation duration on IVF and neonatal outcomes52
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression51
Generation of healthy bovine ovarian organoids: a proof-of-concept derivation technique47
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy47
Evaluation of calcification distribution by CT-based textural analysis for discrimination of immature teratoma47
Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses46
Ginseng alleviates folliculogenesis disorders via induction of cell proliferation and downregulation of apoptotic markers in nicotine-treated mice45
The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study44
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing41
Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study41
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer40
Protective effect of Luffa cylindrica fermentation liquid on cyclophosphamide-induced premature ovarian failure in female mice by attenuating oxidative stress, inflammation and apoptosis35
Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages34
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient34
Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China32
Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer30
Impact of obesity on proteomic profiles of follicular fluid-derived small extracellular vesicles: A comparison between PCOS and non-PCOS women30
The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells29
Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment29
LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC27
Cocultured porcine granulosa cells respond to excess non-esterified fatty acids during in vitro maturation27
0.07291579246521